Related Experiment Video
Updated: Nov 29, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy
Hu Zhang1, Yu Yan1, Qingfeng Hu2
1Department of Endocrinology, Shangqiu First People's Hospital, Shangqiu 476100, Henan, China.
Objective:
The abnormal expression of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) has been demonstrated to exert pivotal effects in human diseases. We focused on the functions of metastasis associated lung adenocarcinoma transcript 1 (MALAT1) and microRNA let-7f on diabetic nephropathy (DN).
Methods:
The diabetes (db/db) mice were treated with silenced MALAT1, then the baseline indicators, pathology changes, marker proteins of podocyte injury (nephrin, podocin, desmin and Cleaved caspase-3), oxidative stress indicators and inflammatory factors in renal tissues were determined. Murine podocyte MPC5 cells were stimulated by high glucose (HG) and transfected with sh-MALAT1 or let-7f mimic, then the cell migration, adhesion ability and apoptosis were evaluated. Moreover, the binding relationship between MALAT1 and let-7f, and the targeting relationship between let-7f and krüppel-like factor 5 (KLF5) were confirmed.
Results:
Silenced MALAT1 could improve baseline indicators of DN mice, and also improved pathology, increased nephrin and podocin expression, decreased desmin and Cleaved caspase-3 expression, and restrained oxidative stress and inflammatory reaction in their renal tissues. Additionally, elevated let-7f and reduced MALAT1 could restrict migration and apoptosis of HG-induced MPC5 cells, and promoted the cell adhesion ability.
Conclusion:
Results in our research indicated that the reduced MALAT1 could relieve the podocyte injury in DN by upregulating let-7f and inhibiting KLF5, which may be helpful for DN therapy.
Insights
Reducing metastasis associated lung adenocarcinoma transcript 1 (MALAT1) alleviates diabetic nephropathy (DN) by increasing microRNA let-7f. This approach protects podocyte injury and offers a potential therapy for DN.
Area of Science:
- Molecular biology
- Genetics
- Nephrology
Background:
- Aberrant expression of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) is implicated in human diseases.
- Metastasis associated lung adenocarcinoma transcript 1 (MALAT1) and microRNA let-7f are investigated for their roles in diabetic nephropathy (DN).
Purpose of the Study:
- To investigate the functions of MALAT1 and let-7f in diabetic nephropathy (DN).
- To explore the therapeutic potential of targeting MALAT1 and let-7f in DN.
Main Methods:
- Diabetes (db/db) mice treated with silenced MALAT1 to assess renal tissue changes and molecular markers.
- Murine podocyte MPC5 cells exposed to high glucose (HG) and transfected with sh-MALAT1 or let-7f mimic to evaluate cell behavior.
- Confirmed binding relationship between MALAT1 and let-7f, and targeting relationship between let-7f and krüppel-like factor 5 (KLF5).
Main Results:
- Silenced MALAT1 improved DN mice indicators, renal pathology, podocyte injury markers (nephrin, podocin), and reduced markers of injury (desmin, Cleaved caspase-3).
- Silenced MALAT1 restrained oxidative stress and inflammation in renal tissues of DN mice.
- Elevated let-7f and reduced MALAT1 restricted migration and apoptosis, while promoting adhesion in HG-induced MPC5 cells.
Conclusions:
- Reduced MALAT1 alleviates podocyte injury in DN by upregulating let-7f and inhibiting KLF5.
- The MALAT1/let-7f/KLF5 axis presents a potential therapeutic target for diabetic nephropathy.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs

